{
    "clinical_study": {
        "@rank": "73881", 
        "arm_group": [
            {
                "arm_group_label": "low level laser therapy", 
                "arm_group_type": "Experimental", 
                "description": "individuals will be subject to the application of low level laser therapy, but this group will have three subdivisions related to dose in joules that will be administered to the individual, and J 4, J 6, 8 J. To be administered in the quadriceps muscle."
            }, 
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "No Intervention", 
                "description": "will consist of individuals diagnosed with diabetes mellitus non-insulin-dependent, however, will not perform low level laser therapy, participate only in the evaluations"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "arm_group_type": "Experimental", 
                "description": "individuals will be subject to the application of low level laser therapy but with a dose of 0 Joules."
            }
        ], 
        "brief_summary": {
            "textblock": "The low level laser therapy is able to improve immediately and long term (after 4 weeks of\n      treatment, 3 days per week resulting in 12 applications of low level laser therapy)\n      isokinetic muscle performance of the quadriceps femoris muscle (peak torque, total muscular\n      work , maximum power and fatigue index - normalized by body weight) pre-exercise concentric\n      isokinetic quadriceps femoris muscle in subjects with diabetes mellitus\n      non-insulin-dependent."
        }, 
        "brief_title": "Effects of Low Power Laser Therapy on Muscle Performance Isokinetic Pre-exercise in Individuals With Diabetes Mellitus Type II", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus Non-insulin-dependent", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "The low level laser therapy is able to improve after 4 weeks of treatment, 3 days per week\n      resulting in 12 applications of low level laser therapy, the indicators: The low level laser\n      therapy is able to improve immediately and long term (after 4 weeks of treatment, 3 days per\n      week resulting in 12 applications of low level laser therapy), the indirect blood markers\n      for muscle damage that evaluate the enzymatic activity of creatine Kinase (CK) and Lactate\n      Dehydrogenase (LDH) and the visual analog scale (VAS-F) for fatigue, improves indicators F\n      2.2 point of the WHOQOL-100 for fatigue, improvement in functional indicators of the lower\n      lower Extremity functional regarding Scale, functional improvement in performance in the\n      execution of the test stand and sit and walk test six minutes, the indicators for quality\n      improvement of life questionnaire for the Diabetes Quality of Life Measure and emotional\n      states through the questionnaire Problems Areas in Diabetes Scale. Eligibility criteria:\n      Diagnosis for Diabetes mellitus non-insulin-dependent confirmed by the individual physician,\n      presenting between 30 to 70 years.Exclusion criteria: Diagnosis of cardiovascular disorders,\n      diagnosis of diabetic neuropathy, which have a skin lesion or local infection (quadriceps),\n      history of musculoskeletal injuries in the last 6 months or during the study, individuals\n      unable to perform the assessment protocols / exercise so satisfactory, those who are doing\n      some kind of regular physical activity and who underwent alcohol intake in the 24 hours\n      before any of the stages of the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis for Diabetes mellitus non-insulin-dependent\n\n          -  Age between 30 to 70 years\n\n        Exclusion Criteria:\n\n          -  Diagnosis of cardiovascular disorders\n\n          -  Diagnosis of diabetic neuropathy,\n\n          -  Skin lesion or local infection (quadriceps)\n\n          -  History of musculoskeletal injuries in the last 6 months or during the study\n\n          -  Individuals unable to perform the assessment protocols or exercise\n\n          -  Regular physical activity\n\n          -  Underwent alcohol intake in the 24 hours before any of the stages of the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01925443", 
            "org_study_id": "U1111-1146-7109"
        }, 
        "intervention": {
            "arm_group_label": [
                "low level laser therapy", 
                "Placebo group"
            ], 
            "description": "Will be performed irradiation with low-intensity laser in quadriceps muscle", 
            "intervention_name": "Low level laser therapy", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "diabetes mellitus non-insulin-dependent", 
            "low level laser therapy"
        ], 
        "lastchanged_date": "November 4, 2013", 
        "link": {
            "url": "http://www.uninove.br"
        }, 
        "location": {
            "contact": {
                "email": "cid.andre@gmail.com", 
                "last_name": "Cid Gomes, MSc", 
                "phone": "+5511970941936"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "zip": "01504-001"
                }, 
                "name": "University of Nove de Julho"
            }, 
            "investigator": {
                "last_name": "Cid Gomes, MSc", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "cid.andre@gmail.com", 
            "last_name": "Cid Gomes, MSc", 
            "phone": "+5511970941936"
        }, 
        "overall_official": {
            "affiliation": "University of Nove de Julho", 
            "last_name": "Cid Gomes, MSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Brazil: Associa\u00e7\u00e3o Fundo de Incentivo \u00e0 Pesquisa", 
                "Brazil: Ethics Committee", 
                "Brazil: Ministry of Health", 
                "Brazil: National Committee of Ethics in Research", 
                "Brazil: National Health Surveillance Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Will use the isokinetic dynamometer to test and evaluate the human musculoskeletal system: peak torque and muscle fatigue of quadriceps.", 
            "measure": "Muscle function", 
            "safety_issue": "No", 
            "time_frame": "2 Years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01925443"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Nove de Julho", 
            "investigator_full_name": "Cid Andr\u00e9 Fidelis de Paula Gomes", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Will be evaluated blood markers (creatine kinase and lactate dehydrogenase) as indirect markers of muscle damage by spectrophotometry using kits specific reagents.", 
                "measure": "Muscle damage", 
                "safety_issue": "No", 
                "time_frame": "2 year"
            }, 
            {
                "description": "In order to assess self-perceived fatigue in day-to-day and immediately after the fatigue protocol will be used two instruments: a visual analog scale (VAS-F) and the question of F2.2 instrument for assessing quality of life World Health Organization (WHOQOL-100).", 
                "measure": "Muscle fatigue", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Functionality will be evaluated using the following assessment tools: Stand and sit test, Six-minute walk test, and Lower Extremity Functional Scale.", 
                "measure": "Functionality", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "The quality of life will be assessed by the questionnaire \"Diabetes Quality of Life Measure\"", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "University of Nove de Julho", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Nove de Julho", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}